New Phase 2 Data Showed that Litifilimab Significantly Reduced Disease Activity in Cutaneous Lupus Erythematosus
The Lupus Research Alliance welcomes new results from the Phase 2 part of the AMETHYST Phase 2/3 study, showing that the...
Stories & News
Submit a Lupus Awareness Month Proclamation in Your Community
May is recognized worldwide as Lupus Awareness Month, a time when attention is focused on lupus, a serious, often overlooked, and frequently misdiagnosed autoimmune disease with...
LRA Progress & Purpose Update | Albert T. Roy – March 2026
Hear from President and CEO Albert T. Roy as he recaps the organization’s exciting achievements from the first months...
Faith Majors: Living with Lupus and Refusing to Give Up
The stats are all too familiar – nine out of ten people with lupus are women. During Women’s History...
New Phase 3 Study Shows that Gazyva® (obinutuzumab) Significantly Reduces Lupus Disease Activity in SLE
A new Phase 3 study published in the New England Journal of Medicine found that Gazyva® (obinutuzumab) significantly reduced disease...
Run 2026 TCS New York City Marathon for Lupus Research
Be Part of Team Life Without Lupus® in the TCS New York City Marathon! AND MAKE HISTORY
On Sunday, November...
Clinical Affiliate Lupus Therapeutics Expands Peer-to-Peer Program
New Centralized Model to Include Hundreds of Research Sites Across North America The clinical affiliate of the Lupus Research Alliance,...
Meet Kendra Latigue: How Learning, Sharing, and a PAL Brought Inspiration
From the first time Kendra Latigue shared her lupus diagnosis on social media, she was surprised to find true...
Lupus Research Alliance and SLEuro Collaborate to Fuel Global Momentum in Lupus
At the 15th European Lupus Meeting, the Lupus Research Alliance Will Present Programmatic Updates, Convene a Scientific Session, and join...
Join our 2026 Virtual Advocacy Day to Support Lupus Research
This year, together with advocates like you, we convinced Congress to restore millions in funding for lupus research. We...
Meet Diana Tive: When Lived Experience Meets Lupus Research
At a very young age, Diana Tive’s life was forever changed with a lupus diagnosis.
Now, two decades later, Diana...
End of Year Message from Lupus Research Alliance President & CEO Albert T. Roy
2025 has been an extraordinary year of momentum at the Lupus Research Alliance and clinical affiliate Lupus Therapeutics. Hear...